Matches in SemOpenAlex for { <https://semopenalex.org/work/W168042919> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W168042919 endingPage "9" @default.
- W168042919 startingPage "1405" @default.
- W168042919 abstract "The aim of study was to investigate the immunophenotype characteristics and prognosis of acute leukemia patients with cross-expressing lymphoid and myeloid lineage-associated antigens. The immunophenotypes of leukemic cells were examined by using flow cytometry. All patients were classified into several groups according to FAB subtypes and immunophenotyping. The cross-expressed antigens analyzed for AML included CD2, CD7, CD19, CD56 and other co-expressed lymphoid antigens. The myeloid antigens analyzed for ALL included CD13 and co-expressed CD13/CD33. ALL and AML patients without expression of cross-expressing antigens were selected as control. Complete remission (CR) ratio and relapse-free survival (RFS) of patients in all groups were compared. The results indicated that among 161 patients analyzed, 91 cases of AML with cross-expressing lymphoid and myeloid antigens included that 24 cases of AML expressed lymphoid surface marker-CD7, namely CD7(+) AML, 14 cases of AML only expressed lymphoid surface marker-CD19, namely CD19(+) AML, 8 cases of AML expressed lymphoid surface marker-CD2 (including CD2/CD19 co-expressed), namely CD2(+) AML, 10 cases of AML expressed lymphoid surface marker-CD56 (including CD56/CD19 or CD56/CD2 co-expressed), namely CD56(+) AML, 16 cases of AML expressed two or more lymphoid surface markers, namely Ly ≥ 2(+) AML, 9 cases of ALL expressed myeloid surface markers CD13, namely CD13(+) ALL, 10 cases of ALL expressed myeloid surface markers CD13 and CD33, namely CD13/CD33(+) ALL. 29 cases of ALL did not expressed myeloid surface markers, namely My(-) ALL, and 41 case of AML did not expressed lymphoid surface markers, namely Ly(-) AML. CR ratio and RFS of Ly ≥ 2(+) AML patients were lower than those of Ly(-) AML patients. RFS of CD56(+) AML patients was lower, but CR ratio had no significant difference, when compared with Ly(-) AML patients. CR ratio and RFS of other AML patients with cross-expressing antigens had no significant difference when compared with Ly(-) AML patients. CR ratio and RFS of CD13(+) ALL and CD13/CD33(+) ALL patients had no significant difference when compared with My(-) ALL patients. It is concluded that the importance of cross-expressing antigens for prognosis of patients should be analyzed concretely. CD56(+) AML and Ly ≥ 2(+) AML have bad prognosis, while other cross-expressed lymphoid and myeloid lineage-associated antigens have no impact on prognosis of acute leukemia patients." @default.
- W168042919 created "2016-06-24" @default.
- W168042919 creator A5018063629 @default.
- W168042919 creator A5064683226 @default.
- W168042919 creator A5072458792 @default.
- W168042919 creator A5080222876 @default.
- W168042919 creator A5088419522 @default.
- W168042919 creator A5089291517 @default.
- W168042919 date "2010-12-01" @default.
- W168042919 modified "2023-09-28" @default.
- W168042919 title "[Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]." @default.
- W168042919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21176339" @default.
- W168042919 hasPublicationYear "2010" @default.
- W168042919 type Work @default.
- W168042919 sameAs 168042919 @default.
- W168042919 citedByCount "2" @default.
- W168042919 countsByYear W1680429192013 @default.
- W168042919 crossrefType "journal-article" @default.
- W168042919 hasAuthorship W168042919A5018063629 @default.
- W168042919 hasAuthorship W168042919A5064683226 @default.
- W168042919 hasAuthorship W168042919A5072458792 @default.
- W168042919 hasAuthorship W168042919A5080222876 @default.
- W168042919 hasAuthorship W168042919A5088419522 @default.
- W168042919 hasAuthorship W168042919A5089291517 @default.
- W168042919 hasConcept C10205521 @default.
- W168042919 hasConcept C113067387 @default.
- W168042919 hasConcept C142724271 @default.
- W168042919 hasConcept C147483822 @default.
- W168042919 hasConcept C1491633281 @default.
- W168042919 hasConcept C176290653 @default.
- W168042919 hasConcept C196166836 @default.
- W168042919 hasConcept C203014093 @default.
- W168042919 hasConcept C2778461978 @default.
- W168042919 hasConcept C2778729363 @default.
- W168042919 hasConcept C2778957590 @default.
- W168042919 hasConcept C2779282312 @default.
- W168042919 hasConcept C28328180 @default.
- W168042919 hasConcept C40722700 @default.
- W168042919 hasConcept C502942594 @default.
- W168042919 hasConcept C54355233 @default.
- W168042919 hasConcept C71924100 @default.
- W168042919 hasConcept C86803240 @default.
- W168042919 hasConceptScore W168042919C10205521 @default.
- W168042919 hasConceptScore W168042919C113067387 @default.
- W168042919 hasConceptScore W168042919C142724271 @default.
- W168042919 hasConceptScore W168042919C147483822 @default.
- W168042919 hasConceptScore W168042919C1491633281 @default.
- W168042919 hasConceptScore W168042919C176290653 @default.
- W168042919 hasConceptScore W168042919C196166836 @default.
- W168042919 hasConceptScore W168042919C203014093 @default.
- W168042919 hasConceptScore W168042919C2778461978 @default.
- W168042919 hasConceptScore W168042919C2778729363 @default.
- W168042919 hasConceptScore W168042919C2778957590 @default.
- W168042919 hasConceptScore W168042919C2779282312 @default.
- W168042919 hasConceptScore W168042919C28328180 @default.
- W168042919 hasConceptScore W168042919C40722700 @default.
- W168042919 hasConceptScore W168042919C502942594 @default.
- W168042919 hasConceptScore W168042919C54355233 @default.
- W168042919 hasConceptScore W168042919C71924100 @default.
- W168042919 hasConceptScore W168042919C86803240 @default.
- W168042919 hasIssue "6" @default.
- W168042919 hasLocation W1680429191 @default.
- W168042919 hasOpenAccess W168042919 @default.
- W168042919 hasPrimaryLocation W1680429191 @default.
- W168042919 hasRelatedWork W2029881670 @default.
- W168042919 hasRelatedWork W204318756 @default.
- W168042919 hasRelatedWork W2149903968 @default.
- W168042919 hasRelatedWork W2152025233 @default.
- W168042919 hasRelatedWork W2238647955 @default.
- W168042919 hasRelatedWork W2328245786 @default.
- W168042919 hasRelatedWork W2337259373 @default.
- W168042919 hasRelatedWork W2356140890 @default.
- W168042919 hasRelatedWork W2357401760 @default.
- W168042919 hasRelatedWork W2364220710 @default.
- W168042919 hasRelatedWork W2380094703 @default.
- W168042919 hasRelatedWork W2391479438 @default.
- W168042919 hasRelatedWork W2399347365 @default.
- W168042919 hasRelatedWork W2402352172 @default.
- W168042919 hasRelatedWork W2416192641 @default.
- W168042919 hasRelatedWork W2763650420 @default.
- W168042919 hasRelatedWork W2979158151 @default.
- W168042919 hasRelatedWork W3030885820 @default.
- W168042919 hasRelatedWork W3210131841 @default.
- W168042919 hasRelatedWork W87524114 @default.
- W168042919 hasVolume "18" @default.
- W168042919 isParatext "false" @default.
- W168042919 isRetracted "false" @default.
- W168042919 magId "168042919" @default.
- W168042919 workType "article" @default.